Josef R. Rüschoff

Staff Status
exunigoe
 

1-22 of 22
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2020 Journal Article
    ​ ​Statistical modelling of HER2-positivity in breast cancer: Final analyses from two large, multicentre, non-interventional studies in Germany​
    Rüschoff, J. ; Lebeau, A.; Sinn, P.; Schildhaus, H.-U. ; Decker, T.; Ammann, J. & Künzel, C. et al.​ (2020) 
    The Breast49 pp. 246​-253​.​ DOI: https://doi.org/10.1016/j.breast.2019.12.005 
    Details  DOI 
  • 2019 Journal Article
    ​ ​Monitoring efficacy of checkpoint inhibitor therapy in patients with non-small-cell lung cancer​
    Schiwitza, A.; Schildhaus, H.-U. ; Zwerger, B.; Rüschoff, J. ; Reinhardt, C.; Leha, A.   & Andreas, S.  et al.​ (2019) 
    Immunotherapy11(9) pp. 769​-782​.​ DOI: https://doi.org/10.2217/imt-2019-0039 
    Details  DOI 
  • 2018 Journal Article | 
    ​ ​Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer​
    Scheel, A. H.; Penault-Llorca, F.; Hanna, W.; Baretton, G.; Middel, P.; Burchhardt, J. & Hofmann, M. et al.​ (2018) 
    Diagnostic Pathology13(1).​ DOI: https://doi.org/10.1186/s13000-018-0696-x 
    Details  DOI 
  • 2018 Journal Article
    ​ ​Optimization and validation of PD-L1 immunohistochemistry staining protocols using the antibody clone 28-8 on different staining platforms​
    Koppel, C.; Schwellenbach, H.; Zielinski, D.; Eckstein, S.; Martin-Ortega, M.; D’Arrigo, C. & Schildhaus, H.-U.  et al.​ (2018) 
    Modern Pathology31(11) pp. 1630​-1644​.​ DOI: https://doi.org/10.1038/s41379-018-0071-1 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer​
    Scheel, A. H; Baenfer, G.; Baretton, G.; Dietel, M.; Diezko, R.; Henkel, T. & Heukamp, L. C et al.​ (2017) 
    Histopathology72(3) pp. 449​-459​.​ DOI: https://doi.org/10.1111/his.13375 
    Details  DOI 
  • 2017 Journal Article
    ​ ​Interlaboratory-concordance of PD-L1 IHC for NSCLC.​
    Scheel, A. H.; Bänfer, G.; Baretton, G. B.; Dietel, M.; Diezko, R.; Henkel, T. & Heukamp, L. C. et al.​ (2017) 
    Journal of Clinical Oncology35(15_suppl) pp. e20508​-e20508​.​ DOI: https://doi.org/10.1200/JCO.2017.35.15_suppl.e20508 
    Details  DOI 
  • 2016 Journal Article | 
    ​ ​Neoadjuvant Therapy in Rectal Cancer - Biobanking of Preoperative Tumor Biopsies​
    Jo, P. ; Nietert, M. M. ; Gusky, L.; Kitz, J. ; Conradi, L.-C. ; Müller-Dornieden, A. & Schueler, P. et al.​ (2016) 
    Scientific Reports6 art. 35589​.​ DOI: https://doi.org/10.1038/srep35589 
    Details  DOI  PMID  PMC  WoS 
  • 2016 Conference Abstract
    ​ ​Neoadjuvant therapy in rectal cancer - challenges of biobanking tumor biopsies taken prior to treatment​
    Jo, P. ; Gusky, L.; Nietert, M. M. ; Kitz, J. ; Conradi, L.-C. ; Müller-Dornieden, A. & Schueler, P. et al.​ (2016)
    Oncology Research and Treatment39 
    Basel​: Karger.
    Details  WoS 
  • 2016 Journal Article
    ​ ​Diagnostic PD-L1 immunohistochemistry in NSCLC: Results of the first German harmonization study.​
    Scheel, A. H.; Dietel, M.; Heukamp, L. C.; Jöhrens, K.; Kirchner, T.; Reu, S. & Ruschoff, J.  et al.​ (2016) 
    Journal of Clinical Oncology34(15_suppl) pp. 3028​-3028​.​ DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.3028 
    Details  DOI 
  • 2015 Journal Article
    ​ ​MET Amplification Status in Therapy-Naive Adeno- and Squamous Cell Carcinomas of the Lung​
    Schildhaus, H.-U. ; Schultheis, A. M.; Rüschoff, J. R. ; Binot, E.; Merkelbach-Bruse, S.; Fassunke, J. & Schulte, W. et al.​ (2015) 
    Clinical Cancer Research21(4) pp. 907​-915​.​ DOI: https://doi.org/10.1158/1078-0432.CCR-14-0450 
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article
    ​ ​HER-2 and HER-3 expression in liver metastases of patients with colorectal cancer​
    Styczen, H.; Nagelmeier, I.; Beißbarth, T. ; Nietert, M. M. ; Homayounfar, K. ; Sprenger, T.   & Boczek, U. et al.​ (2015) 
    Oncotarget6(17) pp. 15065​-15076​.​
    Details  PMID  PMC  WoS 
  • 2014 Journal Article | Research Paper | 
    ​ ​STED Super-Resolution Microscopy of Clinical Paraffin-Embedded Human Rectal Cancer Tissue​
    Ilgen, P. ; Stoldt, S. ; Conradi, L.-C. ; Wurm, C. A. ; Rüschoff, J. ; Ghadimi, B. M.   & Liersch, T.  et al.​ (2014) 
    PLOS ONE9(7) art. e101563​.​ DOI: https://doi.org/10.1371/journal.pone.0101563 
    Details  DOI  PMID  PMC  WoS 
  • 2013 Journal Article
    ​ ​Frequency of HER-2 Positivity in Rectal Cancer and Prognosis​
    Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Wolff, H. A. ; Roedel, C.; Nietert, M. M.   & Homayounfar, K.  et al.​ (2013) 
    American Journal of Surgical Pathology37(4) pp. 522​-531​.​ DOI: https://doi.org/10.1097/PAS.0b013e318272ff4d 
    Details  DOI  PMID  PMC  WoS 
  • 2013 Journal Article
    ​ ​Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival​
    Sprenger, T. ; Conradi, L.-C. ; Beißbarth, T. ; Ermert, H.; Homayounfar, K. ; Middel, P. & Rüschoff, J. R.  et al.​ (2013) 
    Cancer119(1) pp. 26​-35​.​ DOI: https://doi.org/10.1002/cncr.27703 
    Details  DOI  PMID  PMC  WoS 
  • 2013 Conference Abstract
    ​ ​HER-2 and HER-3 expression in locally advanced rectal cancer and metachronous metastases: new targets for treatment approaches?​
    Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Wolff, H. A. ; Middel, P.; Nagelmeier, I. & Rüschoff, J. R.  et al.​ (2013)
    Onkologie36 
    Basel​: Karger.
    Details  WoS 
  • 2013 Journal Article
    ​ ​Preoperative Chemoradiation Therapy With Capecitabine/Oxaliplatin and Cetuximab in Rectal Cancer: Long-Term Results of a Prospective Phase 1/2 Study​
    Fokas, E.; Conradi, L.-C. ; Weiss, C.; Sprenger, T. ; Middel, P.; Rau, T. & Dellas, K. et al.​ (2013) 
    International Journal of Radiation Oncology*Biology*Physics87(5) pp. 992​-999​.​ DOI: https://doi.org/10.1016/j.ijrobp.2013.09.011 
    Details  DOI  PMID  PMC  WoS 
  • 2012 Conference Abstract
    ​ ​Clinical significance and prognostic impact of CD133 expression in rectal cancer treated with preoperative radiochemotherapy​
    Sprenger, T. ; Conradi, L.-C. ; Beißbarth, T. ; Homayounfar, K. ; Rüschoff, J. R. ; Roedel, C. & Ghadimi, M. B.  et al.​ (2012)
    Journal of Clinical Oncology30(15) ​48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)​, Chicago, IL.
    Alexandria​: Amer Soc Clinical Oncology.
    Details  WoS 
  • 2012 Conference Abstract
    ​ ​Cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative triple treatment for rectal cancer (CET-CAPOX-RT-Phase-I/II Study): Influence on long-term survival and relevance of biomarkers​
    Liersch, T. ; Conradi, L.-C. ; Sprenger, T. ; Middel, P.; Suelberg, H.; Roedel, F. & Rüschoff, J. R.  et al.​ (2012)
    Journal of Clinical Oncology30(15) ​48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)​, Chicago, IL.
    Alexandria​: Amer Soc Clinical Oncology.
    Details  WoS 
  • 2012 Conference Abstract
    ​ ​HER-2 in locally advanced rectal cancer (cUICC II/III): positivity rate and prognostic value​
    Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Wolff, H. A. ; Homayounfar, K. ; Becker, H. & Ghadimi, M. B.  et al.​ (2012)
    British Journal of Surgery99 ​99th Annual Congress of the Swiss-Society-of-Surgery​, Davos, SWITZERLAND.
    Malden​: Wiley-blackwell.
    Details  WoS 
  • 2012 Conference Abstract
    ​ ​HER2 status in locally advanced rectal cancer and metachronous metastases: Opportunity for a new therapeutic approach?​
    Conradi, L.-C. ; Styczen, H.; Sprenger, T. ; Homayounfar, K. ; Wolff, H. A. ; Bleckmann, A.   & Rüschoff, J. R.  et al.​ (2012)
    Journal of Clinical Oncology30(15) , Chicago, IL.
    Alexandria​: Amer Soc Clinical Oncology.
    Details  WoS 
  • 2012 Journal Article
    ​ ​CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer​
    Jo, P. ; Jung, K. ; Grade, M. ; Conradi, L.-C. ; Wolff, H. A. ; Kitz, J.   & Becker, H. et al.​ (2012) 
    Surgery151(4) pp. 564​-570​.​ DOI: https://doi.org/10.1016/j.surg.2011.08.013 
    Details  DOI  PMID  PMC  WoS 
  • 2005 Journal Article
    ​ ​Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection Correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis​
    Giuffrè, G.; Müller, A.; Brodegger, T.; Bocker Edmonston, T.; Gebert, J.; Kloor, M. & Dietmaier, W. et al.​ (2005) 
    Journal of Molecular Diagnostics7(2) pp. 160​-170​.​ DOI: https://doi.org/10.1016/S1525-1578(10)60542-9 
    Details  DOI  PMID  PMC  WoS 

Publication List

Type

Subtype

Date issued

Author

Peer-Reviewed

Language

Fulltext

Options

Citation Style

https://publications.goettingen-research-online.de URI: /cris/rp/rp26048
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.